Glycopyrrolate
49 NDCs across 32 manufacturers|48 Generic,1 Brand
Glycopyrrolate is used to treat drug-induced abnormalities, hyperhidrosis, peptic ulcer and respiratory tract diseases, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. In 2024, Medicare Part D spent $10 million on Glycopyrrolate across 245,000 claims for 55,000 beneficiaries.
Glycopyrrolate is available as 49 NDCs from 32 manufacturers (48 generic, 1 brand), with NADAC prices from $0.20 to $1.51 per ML — the most expensive product costs about 7.5× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
49
48G / 1B
Manufacturers
32
competing in market
Price Spread
$0.20 – $1.51
per ML, 28 of 49 NDCs
7d Activity
avg +1.2% WoW · of 49 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Fresenius Kabi USA, LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Anticholinergic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
32 manufacturers producing GLYCOPYRROLATE
Frequently Asked Questions
What is Glycopyrrolate used to treat?
Glycopyrrolate is used to treat drug-induced abnormalities, hyperhidrosis, peptic ulcer and respiratory tract diseases, per the National Library of Medicine's MED-RT classification.
When did Glycopyrrolate become available as a generic?
FDA approved the first generic Glycopyrrolate (ANDA) on Jan 1, 1982.
How much does Medicare spend on Glycopyrrolate?
In 2024, Medicare Part D spent $10 million on Glycopyrrolate across 245,000 claims for 55,000 beneficiaries.
How many Glycopyrrolate products are on the market?
The Glycopyrrolate drug market contains 49 NDCs from 32 manufacturers — 48 generic and 1 brand product.
What is the price range for Glycopyrrolate?
NADAC reference prices for Glycopyrrolate range from $0.2019 to $1.5143 per ML — the most expensive product costs about 7.5× the cheapest. 21 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Glycopyrrolate cheaper than brand?
The average generic NADAC for Glycopyrrolate is $1.2226 per ML, versus $1.0067 for brand-labeled products — brand is currently about 18% cheaper on average.
Which manufacturers make Glycopyrrolate?
32 manufacturers list Glycopyrrolate in NADAC. Ranked by number of NDCs, the largest are Fresenius Kabi USA, LLC (3), Endo USA Inc. (3), Somerset Therapeutics, LLC (2), Civica, Inc. (2), Solco Healthcare US LLC (2).
How has the price of Glycopyrrolate changed recently?
Over the past 7 days, 63 Glycopyrrolate NDCs rose and 13 fell, with a market-wide average change of +1.2%.